OUR
PORTFOLIO
The Verity Pharmaceuticals portfolio focuses on clinically relevant, in-demand prescription therapeutics for the benefit of healthcare providers and their patients across a range of therapeutic areas including Urology, Oncology, Infectious Disease, and Men’s and Women’s Health.
Brands
Trelstar® is a gonadotropin-releasing hormone (GnRH) agonist approved for use in the United States for patients with prostate cancer.
Trelstar® Prescribing Information
To learn more about Trelstar® or to order Trelstar® visit www.trelstar.com
Partnered Brands in Puerto Rico
Akynzeo® is the first and only 5-HT3 and NK1 receptor antagonists fixed combination approved for the prevention of chemotherapy-induced acute and delayed nausea and vomiting.
Akynzeo Prescribing Information
To learn more about Akynzeo® visit www.helsinn.com
Annovera® is a combined hormonal contraceptive vaginal ring that can be used for an entire year.
Annovera Prescribing Information
To learn more about Annovera® visit www.annovera.com
Bijuva® is the first and only FDA-approved combination of bio-identical estradiol and bio-identical progesterone in a single daily oral capsule.
Bijuva Prescribing Information
To learn more about Bijuva® visit www.bijuva.com
Imvexxy® is a softgel vaginal insert used to treat moderate to severe painful sex, a symptom of vulvar and vaginal atrophy (VVA), after menopause.
Imvexxy Prescribing Information
To learn more about Imvexxy® visit www.imvexxy.com
Natesto® is a nasal testosterone replacement therapy used for the treatment of male hypogonadism.
Natesto Prescribing Information
To learn more about Natesto® visit www.natesto.com
Valchlor® is an alkylating drug indicated for the topical treatment of Stage IA and IB mycosis fungoides‐type cutaneous T‐cell lymphoma in patients who have received prior skin‐directed therapy.
Valchlor Prescribing Information
To learn more about Valchlor® visit www.valchlor.com
Vibativ® (telavancin) is an FDA-approved injectable antibiotic used in the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.
Vibativ Prescribing Information
To learn more about Vibativ® visit www.vibativ.com
TRELSTAR® and its designs are licensed trademarks of Verity Pharmaceuticals, Inc.
ANNOVERA is a registered trademark of Population Council and licensed by TherapeuticsMD, Inc.
AKYNZEO is a registered trademark of Helsinn Healthcare SA, Lugano, Switzerland
BIJUVA is a registered trademark of TherapeuticsMD, Inc.
IMVEXXY is a registered trademark of TherapeuticsMD, Inc.
NATESTO® is a registered trademark of Acerus Biopharma Inc.
VALCHLOR® is a registered trademark of Helsinn Birex Pharmaceuticals Ltd., Ireland, distributed and marketed by Helsinn Therapeutics (U.S.), Inc. under license.
VIBATIV® is a registered trademark of Cumberland Pharmaceuticals Inc.